- Home
- RFL vs TOI Comparison
RFL vs TOI Comparison
Compare RFL & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- TOI
- Stock Information
- Founded
- RFL 2017
- TOI 2007
- Country
- RFL United States
- TOI United States
- Employees
- RFL N/A
- TOI N/A
- Industry
- RFL Real Estate
- TOI Medical/Nursing Services
- Sector
- RFL Finance
- TOI Health Care
- Exchange
- RFL Nasdaq
- TOI Nasdaq
- Market Cap
- RFL 48.4M
- TOI 22.7M
- IPO Year
- RFL N/A
- TOI N/A
- Fundamental
- Price
- RFL $1.87
- TOI $0.35
- Analyst Decision
- RFL
- TOI Strong Buy
- Analyst Count
- RFL 0
- TOI 1
- Target Price
- RFL N/A
- TOI $2.50
- AVG Volume (30 Days)
- RFL 58.1K
- TOI 61.3K
- Earning Date
- RFL 12-12-2024
- TOI 11-06-2024
- Dividend Yield
- RFL N/A
- TOI N/A
- EPS Growth
- RFL N/A
- TOI N/A
- EPS
- RFL N/A
- TOI N/A
- Revenue
- RFL $540,000.00
- TOI $361,067,000.00
- Revenue This Year
- RFL N/A
- TOI $29.17
- Revenue Next Year
- RFL N/A
- TOI $16.43
- P/E Ratio
- RFL N/A
- TOI N/A
- Revenue Growth
- RFL 92.86
- TOI 23.31
- 52 Week Low
- RFL $1.29
- TOI $0.27
- 52 Week High
- RFL $2.50
- TOI $2.66
- Technical
- Relative Strength Index (RSI)
- RFL 43.35
- TOI 56.85
- Support Level
- RFL $1.86
- TOI $0.32
- Resistance Level
- RFL $2.50
- TOI $0.39
- Average True Range (ATR)
- RFL 0.12
- TOI 0.02
- MACD
- RFL -0.05
- TOI 0.01
- Stochastic Oscillator
- RFL 4.30
- TOI 51.82
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.